South American destinations such as Mexico, Ecuador, Argentina and Brazil are joining stem cell research communities around the world in seeking stem cell therapies and treatments for conditions such as Multiple Sclerosis, Parkinson's, and Alzheimer's disease. While stem cell research, for all intents and purposes, is still in its infancy, technological breakthroughs in the recent past have encouraged the drive for regenerative adult stem cell therapies to help replace damaged or dead cells and tissues in the human body.
While therapeutic cloning technologies are currently banned in many Latin American countries, stem cell research and treatments, including regenerative theories and methodologies, are under study in locations such as American Stem Cell in Quito, Ecuador and ProgenCell, located in Tijuana, Mexico.
Positive results have been noted in a variety of medical conditions utilizing stem cell therapies, including Parkinson's, Multiple Sclerosis, diabetes, vision problems, and other neurological disease processes. Integra Medical center, located in Tamps, Mexico provides alternative medical treatments and stem cell therapies utilizing a multidisciplinary approach to medicine. Specializing in placental and umbilical cord stem cell therapies, facilities like Integra Medical utilize adult stem cell therapies to treat a wide variety of conditions.
Stem cell therapies focusing on the treatment of Multiple Sclerosis are designed to restore tissue function and to slow and reverse symptoms of Multiple Sclerosis following early diagnosis. Stem cell transplantation offers hope to millions suffering from Multiple Sclerosis and is a leading focus of study in international stem cell communities. Stem cell therapeutics are under development and clinical trial research engaged in treating neuromuscular conditions such as Parkinson's, ALS (Amyotrophic Lateral Sclerosis) and Multiple Sclerosis. Trials conducted throughout Europe, Australia and South America have shown a high percentage of opportunity to slow the progression of the disease process utilizing stem cell replacement therapies.
Because stem cell therapies and treatments have not yet been approved in the United States, though clinical trials are under way, thousands of patients travel to Latin American destinations in the hopes of receiving treatment that may offer increased mobility and quality of life. Stem cell treatments designed to slow or reduced symptoms of Parkinson's and other neuromuscular conditions prompt thousands of global travelers to seek health and wellness throughout Latin America, from Mexico to Ecuador.
Autologous neural stem cell technologies and treatments have shown great promise in the area of treating symptoms caused by diseases like Multiple Sclerosis and Parkinson's, increasing the need to accelerate research findings and provide options for those suffering from such disease processes. Increasing numbers of individuals around the world are demanding more personal choices and auctions in their healthcare, which is not limited by borders.
Stem cell research facilities throughout Latin America offer hope for the future with affordable, accessible, and promising treatments and therapies in stem cell research, technologies, methodologies and potential treatment plans.
PlacidWay | Stem Cell Treatment in Latin America 2010-02-24 Articles/Press Releases